NCT04949906View on ClinicalTrials.gov

Study on Yangxue Nao Granules Reducing the Risk of Stroke

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

September 1, 2020

Study Completion Date

November 1, 2020

Conditions
Cerebral Infarction
Interventions
DRUG

Raise serum brain granules

Should Yangseronao granules be used in patients undergoing intravenous thrombolysis for the diagnosis of acute ischemic stroke

DRUG

No nourishing serum brain granules are used

No nourishing serum brain granules are used

Trial Locations (1)

Unknown

Peking Yniversity Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT04949906 - Study on Yangxue Nao Granules Reducing the Risk of Stroke | Biotech Hunter | Biotech Hunter